Where the Money Goes

You are here

Home » Northwestern Mutual Foundation

Northwestern Mutual Foundation

The mission of the Northwestern Mutual Foundation is to improve the lives of children and families in need. The Foundation has given more than $35 million since its inception in 1992 and is designed to create lasting impact in the communities where the company's employees and financial representatives live and work. We accomplish this by combining financial support, volunteerism, thought leadership and convening community partners to deliver the best outcomes. Our efforts are focused nationally on curing childhood cancer, and locally on education, neighborhoods and making our hometown of Milwaukee a great destination.

Visit Northwestern Mutual Foundation for more information

Co-Funded Projects

Project Title Institutions Co-Funder(s)
Development of Mithramycin Analogs for Ewing sarcoma Van Andel Research Institute Northwestern Mutual Foundation
Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML Children’s Hospital of Wisconsin - Milwaukee Northwestern Mutual Foundation
Identifying Disease Mechanisms and Therapeutic Opportunities in Pediatric Low-grade Gliomas Driven by MYB-QKI Fusions Dana-Farber Cancer Institute Northwestern Mutual Foundation
High-Throughput Gene-Editing via Microfluidic Cell Deformability to Enable Off-the-Shelf Allogeneic Cellular Immunotherapies University of California, Los Angeles Northwestern Mutual Foundation
The Impact of Hypoxia on Epigenetic Changes in Neuroblastoma University of Chicago Northwestern Mutual Foundation
Development and Characterization of Novel Models of Human Osteosarcoma Development and Metastasis University of Minnesota Northwestern Mutual Foundation
Reactivation of p53-Mediated Apoptosis in Neuroblastoma Dana-Farber Cancer Institute Northwestern Mutual Foundation
A Characterization of TP53 Mutations Among Pediatric Osteosarcoma Cases University of Minnesota Northwestern Mutual Foundation
ABVD Without Radiation for Newly Diagnosed Pediatric Patients with Hodgkin Lymphoma: A Single Center Retrospective Analysis of 22 Consecutive Patients University of California San Francisco Northwestern Mutual Foundation
Targeting Eya2 to Inhibit c-Myc Driven Medulloblastoma Tumor Progression - Connor Farnham (2017) University of Colorado Denver Northwestern Mutual Foundation

Pages

Featured Hero

Chris Ramirez

Chris loves baseball – he has a history of playing for his high school team and is a longtime fan of the San Francisco Giants. However, when he was in high school, Chris began having strange symptoms. Today, Chris is a three-time survivor of glioblastoma.
Read more »